Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2.

Hsiao-Ling ChiangKang-Hao LiangRuei-Min LuTing-Wen KuoYi-Ling LinHan-Chung Wu

Published in: Journal of biomedical science (2023)

Thus, our efficient screening of BA.5-specific neutralizing hAbs from breakthrough infectious convalescent donors successfully yielded hAbs with potent therapeutic potential against multiple SARS-CoV-2 variants.

Keyphrases

sars cov
dengue virus
respiratory syndrome coronavirus
endothelial cells
copy number
pluripotent stem cells
zika virus
kidney transplantation
anti inflammatory
coronavirus disease